Researcher
Sigrid Stroobants
- Keywords:Medicine
- Disciplines:Cancer diagnosis, Biomarker evaluation, Nuclear imaging, Neurosciences not elsewhere classified
Affiliations
- Molecular Imaging and Radiology (MIRA) (Research group)
Responsible
From1 Jan 2019 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Member
From1 Sep 2008 → 31 Dec 2018
Infrastructure
1 - 1 of 1
- Flanders BioImaging (FBI/EBI) (Consortium partner)
Projects
1 - 10 of 29
- Flanders BioImaging: Leading Imaging Application Integrated Service and Enablement (FBI-LIAISE).From1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- Diagnostic and theranostic targeting of fibroblast activation protein (FAP) with goed nanoparticles decorated with FAPIs and FAPI fragments.From1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Development of theranostic ligands for fibroblast activation protein with improved pharmacokinetic profile.From1 Sep 2022 → 31 Aug 2023Funding: IOF - technology validation in lab
- Biomarker and therapy development through in vivo Molecular Imaging of small animals.From1 Jun 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Validation of autophagy induction as a therapeutic strategy: from drug discovery and preclinical evaluation to safety investigation and biomarker research.From1 Jan 2021 → TodayFunding: BOF - projects
- Positron emission tomography combined with innovative laboratory techniques for improved risk and disease assessment in myeloma.From1 Jan 2021 → TodayFunding: FWO Applied Biomedical Research (TBM)
- IMARK. Network for image-based biomarker discovery and evaluationFrom1 Jan 2021 → TodayFunding: IOF - mandates
- Improved PET probes for predicting and imaging immunotherapy responses.From1 Oct 2020 → 30 Sep 2023Funding: FWO senior postdoctoral fellowship
- Biopharmaceutical optimization of PET-diagnostic tools targeting fibroblast activation protein (FAP).From1 May 2020 → 30 Sep 2021Funding: IOF - technology validation in lab
- Multidimensional analysis of the nervous system in health and disease (µNeuro).From1 Jan 2020 → TodayFunding: BOF - research organisations, Fund Recuperation Fiscal Exemption
Publications
11 - 20 of 155
- Longitudinal preclinical evaluation of the novel radioligand [¹¹C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's disease(2022)
Authors: Daniele Bertoglio, Jeroen Verhaeghe, Alan Miranda Menchaca, Leonie Wyffels, Sigrid Stroobants, Ladislav Mrzljak, Vinod Khetarpal, Mette Skinbjerg, Longbin Liu, Celia Dominguez, et al.
Pages: 1166 - 1175 - Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy(2022)
Authors: Frederik Soffers, Nils Helsen, Tim Van den Wyngaert, Laurens Carp, Otto S. Hoekstra, Laurence Goethals, Michel Martens, Kristof Deben, Karoline Spaepen, Remco De Bree, et al.
Pages: 1 - 11 - Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements(2022)
Authors: J.J. Eertink, A.I.J. Arens, J.E. Huijbregts, F. Celik, B. de Keizer, Sigrid Stroobants, D. de Jong, S.E. Wiegers, G.J.C. Zwezerijnen, C.N. Burggraaff, et al.
Pages: 943 - 952 - Validation, kinetic modeling, and test-retest reproducibility of [¹⁸F]SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2A in mice(2022)
Authors: Daniele Bertoglio, Franziska Zajicek, Alan Miranda Menchaca, Sigrid Stroobants, Yuchuan Wang, Celia Dominguez, Ignacio Munoz-Sanjuan, Jonathan Bard, Longbin Liu, Jeroen Verhaeghe, et al.
Pages: 1867 - 1878 - Spatiotemporal Kernel reconstruction for linear parametric neurotransmitter PET kinetic modeling in motion correction brain PET of awake rats(2022)
Authors: Alan Miranda Menchaca, Daniele Bertoglio, Sigrid Stroobants, Steven Staelens, Jeroen Verhaeghe
Pages: 1 - 14 - Estimation of the net influx rate Ki and the cerebral metabolic rate of glucose MRglc using a single static [¹⁸F]FDG PET scan in rats(2021)
Authors: Steven Deleye, Alan Miranda Menchaca, Sigrid Stroobants, Steven Staelens, Jeroen Verhaeghe
- Kinetic modelling and test-retest reproducibility for the dopamine D₁R radioligand [¹¹C]SCH23390 in healthy and diseased mice(2021)
Authors: Jeroen Verhaeghe, Alan Miranda Menchaca, Leonie Wyffels, Sigrid Stroobants, Celia Dominguez, Ignacio Munoz-Sanjuan, Mette Skinbjerg, Longbin Liu, Steven Staelens
Pages: 208 - 219 - ATG4B inhibitor UAMC-2526 potentiates the chemotherapeutic effect of gemcitabine in a Panc02 mouse model of pancreatic ductal adenocarcinoma(2021)
Authors: Sedigheh Takhsha, Christel Vangestel, Muhammet Tanc, Sven De Bruycker, Maya Berg, Isabel Pintelon, Sigrid Stroobants, Guido De Meyer, Pieter Van Der Veken, Wim Martinet
- Early changes in [¹⁸F]FDG uptake as a readout for PI3K/Akt/mTOR targeted drugs in HER-2-positive cancer xenografts(2021)
Authors: Yanina Dockx, Christel Vangestel, Tim Van den Wyngaert, Manon Huizing, Sven De Bruycker, Patrick Pauwels, Steven Staelens, Sigrid Stroobants
- Low activity [¹¹C]raclopride kinetic modeling in the mouse brain using the spatiotemporal kernel method(2021)
Authors: Alan Miranda Menchaca, Sigrid Stroobants, Steven Staelens, Jeroen Verhaeghe
Patents
1 - 3 of 3